Similar articles for PMID: 19351753

Year	Number of Results
1995	1
1997	3
1998	1
1999	2
2000	3
2001	3
2002	9
2003	10
2004	7
2005	8
2006	14
2007	8
2008	5
2009	7
2010	3
2011	4
2013	1
2014	2
2015	3
2016	1
2017	2
2018	1
2019	2
2020	3
2021	1
2022	1
2024	0

1

G3139, an anti-Bcl-2 antisense oligomer that binds heparin-binding growth factors and collagen I, alters in vitro endothelial cell growth and tubular morphogenesis.

Stein CA, Wu S, Voskresenskiy AM, Zhou JF, Shin J, Miller P, Souleimanian N, Benimetskaya L. Stein CA, et al. Clin Cancer Res. 2009 Apr 15;15(8):2797-807. doi: 10.1158/1078-0432.CCR-08-2610. Epub 2009 Apr 7. Clin Cancer Res. 2009. PMID: 19351753 Free PMC article.

2

Comparison of d-g3139 and its enantiomer L-g3139 in melanoma cells demonstrates minimal in vitro but dramatic in vivo chiral dependency.

Lai JC, Brown BD, Voskresenskiy AM, Vonhoff S, Klussman S, Tan W, Colombini M, Weeratna R, Miller P, Benimetskaya L, Stein CA. Lai JC, et al. Mol Ther. 2007 Feb;15(2):270-8. doi: 10.1038/sj.mt.6300037. Mol Ther. 2007. PMID: 17235304 Free article.

3

Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.

Loomis R, Carbone R, Reiss M, Lacy J. Loomis R, et al. Clin Cancer Res. 2003 May;9(5):1931-9. Clin Cancer Res. 2003. PMID: 12738752

4

Bcl-2 protein in 518A2 melanoma cells in vivo and in vitro.

Benimetskaya L, Ayyanar K, Kornblum N, Castanotto D, Rossi J, Wu S, Lai J, Brown BD, Popova N, Miller P, McMicken H, Chen Y, Stein CA. Benimetskaya L, et al. Clin Cancer Res. 2006 Aug 15;12(16):4940-8. doi: 10.1158/1078-0432.CCR-06-1002. Clin Cancer Res. 2006. PMID: 16914583

5

G3139 induces cell death by caspase-dependent and -independent apoptosis on human melanoma cell lines.

Nakamura S, Inui M, Kamei T, Nakase M, Okumura K, Tagawa T. Nakamura S, et al. Oncol Rep. 2006 Jun;15(6):1563-8. Oncol Rep. 2006. PMID: 16685396

6

Gene profiling study of G3139- and Bcl-2-targeting siRNAs identifies a unique G3139 molecular signature.

Anderson EM, Miller P, Ilsley D, Marshall W, Khvorova A, Stein CA, Benimetskaya L. Anderson EM, et al. Cancer Gene Ther. 2006 Apr;13(4):406-14. doi: 10.1038/sj.cgt.7700901. Cancer Gene Ther. 2006. PMID: 16195754

7

Relative Bcl-2 independence of drug-induced cytotoxicity and resistance in 518A2 melanoma cells.

Benimetskaya L, Lai JC, Khvorova A, Wu S, Hua E, Miller P, Zhang LM, Stein CA. Benimetskaya L, et al. Clin Cancer Res. 2004 Dec 15;10(24):8371-9. doi: 10.1158/1078-0432.CCR-04-1294. Clin Cancer Res. 2004. PMID: 15623615

8

Induction of apoptosis by G3139 in melanoma cells.

Benimetskaya L, Lai JC, Khvorova A, Wu S, Miller P, Stein CA. Benimetskaya L, et al. Ann N Y Acad Sci. 2005 Nov;1058:235-45. doi: 10.1196/annals.1359.033. Ann N Y Acad Sci. 2005. PMID: 16394140 Review.

9

Electroporation increases antitumoral efficacy of the bcl-2 antisense G3139 and chemotherapy in a human melanoma xenograft.

Spugnini EP, Biroccio A, De Mori R, Scarsella M, D'Angelo C, Baldi A, Leonetti C. Spugnini EP, et al. J Transl Med. 2011 Jul 28;9:125. doi: 10.1186/1479-5876-9-125. J Transl Med. 2011. PMID: 21798045 Free PMC article.

10

Activation of the FGF2/FGFR1 autocrine loop for cell proliferation and survival in uveal melanoma cells.

Lefèvre G, Babchia N, Calipel A, Mouriaux F, Faussat AM, Mrzyk S, Mascarelli F. Lefèvre G, et al. Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1047-57. doi: 10.1167/iovs.08-2378. Epub 2008 Nov 21. Invest Ophthalmol Vis Sci. 2009. PMID: 19029025

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year